How Hall was paid
$3.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Christopher HallChief Executive Officer and Director | $618,000 | $853,050 | $1,784,728 | $247,200 | $3,000 | $3,505,978 |
| Aaron TachibanaChief Financial Officer and Chief Operating Officer | $545,900 | $272,250 | $656,150 | $131,000 | $3,000 | $1,608,300 |
| Richard Chen, M.D., M.S.President, Executive Vice President, Research and Development and Chief Medical Officer | $530,450 | $272,250 | $656,150 | $127,300 | $3,000 | $1,589,150 |
What changed and why
- $3.5MChristopher Hall received total compensation of $3,505,978 in 2025, compared to $1,535,960 in 2024.
- A significant portion of executive compensation is at-risk, performance-based compensation.
- 96.12%Stockholders approved executive compensation by approximately 96.12% at the 2025 say-on-pay vote.
- 4.0%Base salaries for named executive officers increased by 4.0% for merit in 2025.
- Corporate goals for 2025 cash bonuses included total GAAP-based revenue versus budget.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.